Jasper Therapeutics Inc JSPR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EST
4.36UNCH (UNCH)
Volume
8,939
Close
4.36UNCH (UNCH)
Volume
42,482
52 week range
4.11 - 18.88
Loading...
  • Open4.44
  • Day High4.66
  • Day Low4.25
  • Prev Close4.36
  • 52 Week High18.88
  • 52 Week High Date10/15/21
  • 52 Week Low4.11
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap165.03M
  • Shares Out37.85M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-44.46

KEY STATS

  • Open4.44
  • Day High4.66
  • Day Low4.25
  • Prev Close4.36
  • 52 Week High18.88
  • 52 Week High Date10/15/21
  • 52 Week Low4.11
  • 52 Week Low Date01/24/22
  • Market Cap165.03M
  • Shares Out37.85M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.02
  • YTD % Change-44.46

RATIOS/PROFITABILITY

  • EPS (TTM)-0.68
  • P/E (TTM)-6.44
  • Fwd P/E (NTM)-1.37
  • EBITDA (TTM)-24.727M
  • ROE (TTM)-31.34%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Jasper Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Jasper Therapeutics, Inc., formerly Amplitude Healthcare Acquisition Corporation, is a biotechnology company focused on hematopoietic cell transplant therapies. The Company has developed programs, such as JSP191, an anti-CD117 monoclonal antibody, which is in clinical development as a conditioning agent that clears hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It is designed to enable curative allogeneic and autologous...
Address
2200 Bridge Pkwy Suite #102,
Redwood City, CA
94065
United States